pocket programme - world-heart-federation.org · pocket programme. schedule overview wednesday 5th...

POCKET PROGRAMME

Schedule Overview Wednesday 5th December 2018

Dat

eEx

hibi

tion

&

E-Po

ster

sSa

telli

te

Sym

posi

aR

egis

trat

ion

Spea

ker

Prev

iew

Net

wor

king

Tues

day

4 D

ecem

ber 2

018

15:0

0 - 1

8:00

15:0

0 - 1

8:00

Wed

nesd

ay 5

D

ecem

ber 2

018

10:4

5 - 1

8:00

07:0

0 - 1

8:30

07:0

0 - 1

8:30

12:3

0 - 1

3:30

Wel

com

eR

ecep

tion

Thur

sday

6

Dec

embe

r 201

810

:00

- 18:

0012

:30

- 13:

3007

:30

- 18:

0007

:30

- 19:

3018

:00

- 19:

00

Frid

ay 7

D

ecem

ber 2

018

10:0

0 - 1

8:00

13:0

0 - 1

4:00

08:0

0 - 1

8:00

07:3

0 - 1

9:30

Satu

rday

8

Dec

embe

r 201

810

:00

- 17:

0012

:30

- 13:

3008

:00

- 18:

0007

:30

- 19:

3017

:45

- 18:

15C

losi

ngC

erem

ony

Shei

kh

Ras

hid

ESh

eikh

R

ashi

d A

Shei

kh

Ras

hid

BSh

eikh

M

akto

um C

Shei

kh

Mak

toum

D

08:0

0 - 1

0:50

The

6th

Inte

rnat

iona

l C

onfe

renc

e on

W

omen

, Hea

rt D

isea

se a

nd S

troke

Prim

ary

Hea

lth C

are

Phys

icia

nsW

orks

hop

Med

ical

St

uden

ts

Wor

ksho

p

11:0

0 - 1

2:30

Ope

ning

C

erem

ony

13:4

5 - 1

7:10

The

6th

Inte

rnat

iona

l C

onfe

renc

e on

W

omen

, Hea

rt D

isea

se a

nd S

troke

Prim

ary

Hea

lth C

are

Phys

icia

nsW

orks

hop

Med

ical

St

uden

tsW

orks

hop

15:0

0 - 1

7:30

Mee

t &

Shar

e Fo

rum

Allied Health ProfessionalsArrhythmiasCardiac ImagingClinical caseEpidemiology / Prevention / Health promotion / Physical Activity / AdvocacyFetal SessionGenetics / Epigenetics / Technology / E-HealthHeart Disease in WomenHeart Failure / Left Ventricular Function / Myocardial Pericardial Disease / Chagas DiseaseHypertension / Obesity / Dyslipidemia / Diabetes and Metabolic DisordersIschaemia / Coronary Artery Disease / Coronary Interventions / Acute Coronary SyndromeMeet and Share ForumOpening CeremonyPaediatrics / Adolescent / Congenital heart diseasePlenary sessionPre CongressSatellite SymposiumStroke / Peripheral Circulation / Non-Coronary Interventions / Aorto-ArteritisValvular Disease / RHD / Pulmonary Circulation / Valvular InterventionWHF Member partners joint sessionWoman session

Thursday 6th December 2018Sheikh

Rashid ESheikh

Rashid ASheikh

Rashid BSheikh

Maktoum ASheikh

Maktoum CSheikh

Maktoum DDubai C & D

Abu Dhabi B

08:30 - 09:15

Plenary: Putting guidelines in

clinical context!

09:30 - 10:30

European Society of Cardiology Session:

Hot topics in clinical cardiology

The Role of Imaging in prevention

Novel therapies to reduce

cardiovascular risk

Glycemic and lipid metabolic disorders Meet & Share Forum Cardiac Imaging

Debate

Strengthening primary health care - Community

based vascular prevention and management across

the globe

11:00 - 12:00

Japanese Circulation Society Session:

Hot topics of coronary disease and heart failure

Natriuretic Peptide Guided

Therapy for Heart Failure

is Dead

Guidelines in a nutshell

Cardiac Imaging: Clinical Cases Meet & Share Forum Limb Ischemia

12:30 - 13:30

Industry Symposium:Diabetes, Cardiology & Novel Therapeutic

Approaches: Science, Outcomes & Practice

*EBAC accredited symposium Supported by PACE-CME via an

unrestricted educational grant provided by Novo Nordisk

Industry Symposium: Boehringer Ingelheim

Novel approaches in

management of Cardiovascular

risk

Industry Symposium:

Merck The impact of Sympathetic

Overdrive along the CV continuum

Industry Symposium:

SanofiIndividualizing

treatment strategies post ACS: from

concept to clinical practice

Industry Symposium:

ServierNew ESC/ESH guidelines inhypertension:

implementationin clinical practice

Industry Symposium:Pfizer Gulf

Stroke Prevention in Afib:

From Clinical Trials to Clinical Practice

14:00 - 14:45

Plenary: Bringing cardiac surgery to the

people

15:00 - 16:00

Rheumatic Fever: What is new, novel, and innovative?

Risk stratification & prediction of

events

Managing CVD in low-income

settings

Improving patient experience with CVD risk reduction: the role

of technology

Meet & Share Forum

WHF & Inter-American Society of Cardiology

Joint Session: Selected topics of

valvular heart disease

Genetics and global CVD burden

16:30 - 17:30

Rheumatic Heart Disease – Nurses taking up the

challenge

High Density Lipoproteins: the Good, the Bad, the Ugly

American Heart Association

Session: Tackling cardiovascular

disease: guidelines and quality

improvement

Stroke prevention in atrial fibrillation Meet & Share Forum

WHF & World Stroke Organization joint

session: Ischemic Stroke

Addressing the global burden of heart

disease in children

18:00 - 19:30

Industry Symposium: Servier

New opportunities for treating cardiac

patients: from angina to heart failure

Industry Symposium: Astra Zeneca

CVOTs in Diabetes - The Next Chapter

Friday 7th December 2018Sheikh

Rashid ESheikh

Rashid ASheikh

Rashid BSheikh

Maktoum ASheikh

Maktoum CSheikh

Maktoum DDubaiC & D

Abu Dhabi B

08:30 - 09:15

Plenary: Myths about diet and

CVD

09:30 - 10:30

WHF & Asia Pacific Society of Cardiology joint session:

Management of hypertension

Diabetes and Heart Failure

American College of Cardiology Session:

Opportunities in resource challenged

settings

Practical spproaches to reduce

cardiovascular risk factor

Meet & Share Forum

Interventional therapies for adults

with congenital heart disease

Stable CAD

11:00 - 12:00

Prevention of sudden cardiac death

Saudi Heart Association

session: Heart failure management

Diagnostic testing and prognostication

in CAD

A challenging case for primary

prevention Meet & Share Forum

Cardiac disease in pregnancy -

Meet the expert

New Frontiers in Cardiac

Rehabilitation and Secondary Prevention

13:00 - 14:00

Industry Symposium:

BayerShould we reduce the

dose of NOACs in our frail AF patients to reduce the

risk of bleeding?

Industry Symposium:

PfizerATTR Cardiomyopathy

Hidden in the Shadows of Heart Failure

Industry Symposium:

AmgenOptimising CV Outcome

With EVOLOCUMAB, Choosing the Right

Patient

14:00 - 14:45

Plenary: The Past, Present, and Future of

CVD in Women

15:00 - 16:00

Optimal management Strategies in CAD

Rheumatic Heart Disease - Basic science

EORP Registries. EUROASPIRE

V Study on CVD Prevention and

Diabetes- principal results in patients at high CVD risk in

primary care

Menopausal hormone therapy

in the prevention of cardiovascular

disease

Fetal Heart Session I

16:30 - 17:30

Polypill or Individual risk factor management?

Lipids and prevention of

acute coronary syndrome:

What’s new?

Imaging in valvular heart disease

Cardiogenic stroke

Global burden of CVD

Bringing quality and affordable healthcare to communities

Fetal Heart Session II

18:00 - 19:30

Saturday 8th December 2018Sheikh

Rashid ESheikh

Rashid ASheikh

Rashid BSheikh

Maktoum ASheikh

Maktoum CSheikh

Maktoum DDubaiC & D

Abu Dhabi B

08:30 - 09:15

Plenary: Managing

acute coronary syndromes: from

Eisenhowers heart attack to the future of cardiology

09:30 - 10:30

Cardiac imaging in 2030: predicting the future

Familial Hyper-cholesterolemia Session : Rec-ognize Familial Hypercholester-

olemia and save lives

Live Case from Rashid Hospital - Dubai Health

Authority: Challenges in Cath Lab

Controversies in hypertension

The Dysfunctional RVOT - SYM

Real world prevention of stroke in atrial fibrillation: how

guidelines are applied

11:00 - 12:00

Practical approaches for unique cases

The role of imaging in

heart failure

WHF & Pan-African Society of Cardiol-ogyJoint session:

Mitral regurgitation, current status and future directions

Controversies and difficult patient

management - HFpEF, HFmrEF, HFrE

Round table on Cardio-vascular Risk Assessment

and Prediction Charts, Online Tools, Biomarkers,

and Imaging?

Rheumatic Heart Disease - Prevention

Rheumatic fever and rheumatic

valve disease cases

12:30 - 13:30

Industry Symposium:

NovartisIn Heart Failure, the

sooner the better

14:00 - 14:45

Plenary: Eliminating acute rheumatic fever

in the world - could this be

a reality?

15:00 - 16:00

LVAD and transplant: Patient selection and post

VAD complications and management

Pulmonary hyptertension

Reducing cardiovascular risk in the population

CVD in women: Is it different?

Chinese Society of Cardiology Session :

Strategies and measure for Chinese

cardiovascular diseases

Looking toward the future of

cardiovascular medicine

Modern concepts in valvular disease

16:30 - 17:30

Relating diabetes and CVD:

Is all the same?

Understanding HFpEF

Atrial fibrillation ablation

Hypertension in women across the lifespan

Cardiac impact of infectious disease

17:45 - 18:15 Closing Ceremony

Congress Venue Floorplan

ENTRANCE(Novotel)

Registration Area

ExhibitionHalls

Catering &E-Posters

Con

cour

se 2

Con

cour

se 2

Al

Mul

taqu

a Ba

llroo

mIbis Hotel

SheikhRashid Halls

Mul

ti - S

tore

y Pa

id P

arki

ng

First Floor

First FloorFirst Floor

First Floor

Fujairah-C

Fujairah-B

Fujairah-A

Ajman-D

Hall 8

DC

A

Sheikh Maktoum Halls

AB

E

Glo

bal

Sum

mit

Pres

s W

orki

ng &

In

terv

iew

Roo

m

SpeakerPreviewRoom

ENTRANCE(Exhibition Gate)

Dubai-B

Dubai-C

Dubai-D

Dubai-E

Dubai-F

Dubai-A

Abu Dhabi-A

Abu Dhabi-B

Ajman-C

Ajman-B

Ajman-A

Sharjah-D

Sharjah-Foyer

First Floor

ENTRANCE(Novotel)

Registration Area

ExhibitionHalls

Catering &E-Posters

Con

cour

se 2

Con

cour

se 2

Al

Mul

taqu

a Ba

llroo

mIbis Hotel

SheikhRashid Halls

Mul

ti - S

tore

y Pa

id P

arki

ng

First Floor

First FloorFirst Floor

First Floor

Fujairah-C

Fujairah-B

Fujairah-A

Ajman-D

Hall 8

DC

A

Sheikh Maktoum Halls

AB

E

Glo

bal

Sum

mit

Pres

s W

orki

ng &

In

terv

iew

Roo

m

SpeakerPreviewRoom

ENTRANCE(Exhibition Gate)

Dubai-B

Dubai-C

Dubai-D

Dubai-E

Dubai-F

Dubai-A

Abu Dhabi-A

Abu Dhabi-B

Ajman-C

Ajman-B

Ajman-A

Sharjah-D

Sharjah-Foyer

First Floor

List of Exhibitiors & Sponsors

Company Booth no.

Abbott Laboratories S.A. .....................G08

Actelion ...............................................G02

AHA CPR AREA .................................. F03

Algorithm S.A.L ...................................H09

American College of Cardiology .........C08

American Heart Association ................C04

Amgen .................................................G01

Asian Pacific Society of Cardiology .... E06

AstraZeneca FZ LLC ...........................H01

Bayer ...................................................C05

Boerhinger Ingelheim .......................... E03

CardioAlex / CVREP ........................... E07

CNSystems Medizintechnik GmbH ....B05

Emirates Cardiac Society ....................C02

European Society of Cardiology .........C03

GlaxoSmithKline..................................H08

Gulf Heart Association ........................B09

HeartSciences .....................................G06

HIKMA ..........................................Sponsor

Ideal Protein ........................................H10

International Atherosclerosis Society .................................................C09

JULPHAR .....................................Sponsor

Menarini...............................................H07

Company Booth no.

Merck ................................................... F01

MSD ....................................................C01

NCD CAFE ..........................................H05

Novartis ...............................................B01

OXFORD UNIVERSITY PRESS ........B06

Pfizer Gulf............................................ E01

Physicians’ Academy for Cardiovascular Education (PACE-CME) ................................Sponsor

Public Health Foundation of India .......C07

Reach ..................................................D06

SAJA Pharmaceuitcals........................G09

Sanofi ..................................................D01

Saudi Heart Association ......................D05

SERVIER ............................................ F02

SHERWOOD................................Sponsor

South African Heart Association .........D09

Stryker ................................................. E04

Sudan Heart Society ........................... E05

WeHealth by Servier ...........................B02

World Heart Federation Arena ............D03

Wolters Kluwer ....................................G03

World Heart Federation .......................D02

The World Heart Federation would like to thank the following partners for their contribution to WCC 2018.

Notes

Exhibition Floorplan

Posters

Bayer

ESC

Gulf HeartAssociation

Boerhinger Ingelheim

WHF Arena

Member Area

Stryker

AHA CPR Area

Servier International

Novartis

MSD

Sanofi Pfizer

AmgenMerck

EmiratesCardiacSociety

We Health

by Servier

Comm

on space

Posters

Posters

Seating AreaSeating Area

American Heart

Association

HeartArt

Abbott

NCD Cafe

Astra Zeneca

Actelion

HeartSciences

SAJACardioAlex

AsianPacific

SudanHeartAssoc

FutureEvents

SaudiHeartAssn

PublicHealthof India

Oxford Uni

Press

CNS

IntlAtheros-clarosis

ACC

SouthAfricanAssn

Reach

Ideal ProteinAlgorithm

Menarini

B09C05 C06 C07 D05 D06 D09 E05 E08

G06

G08

G07 H09 H10

H07 H08

E06 E07 G11C08 C09

B02 C03 D02 E03

E02 G02 G03

F02 G04

H05

B01C02 E01

F01 G01 H03

D01

C01 H01

B06 C04 D03 E04 F03

B05

GSK

WoltersKluwer

ENTRANCEEXITENTRANCEEXIT

Posters

Bayer

ESC

Gulf HeartAssociation

Boerhinger Ingelheim

WHF Arena

Member Area

Stryker

AHA CPR Area

Servier International

Novartis

MSD

Sanofi Pfizer

AmgenMerck

EmiratesCardiacSociety

We Health

by Servier

Comm

on space

Posters

Posters

Seating AreaSeating Area

American Heart

Association

HeartArt

Abbott

NCD Cafe

Astra Zeneca

Actelion

HeartSciences

SAJACardioAlex

AsianPacific

SudanHeartAssoc

FutureEvents

SaudiHeartAssn

PublicHealthof India

Oxford Uni

Press

CNS

IntlAtheros-clarosis

ACC

SouthAfricanAssn

Reach

Ideal ProteinAlgorithm

Menarini

B09C05 C06 C07 D05 D06 D09 E05 E08

G06

G08

G07 H09 H10

H07 H08

E06 E07 G11C08 C09

B02 C03 D02 E03

E02 G02 G03

F02 G04

H05

B01C02 E01

F01 G01 H03

D01

C01 H01

B06 C04 D03 E04 F03

B05

GSK

WoltersKluwer

ENTRANCEEXITENTRANCEEXIT

D8546-Pub-ESC-Congress2019-A6_v5.indd 1 13/11/2018 16:25